Dong Kim

Insider Reports History

Location
Princeton, NJ
Signature
/s/ Randy Milby as Attorney-In-Fact for Dong Kim
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dong Kim:

Company Role Class Num Shares Value Price $ Report Date Ownership
UroGen Pharma Ltd. Chief Financial Officer Ordinary Shares 37,753 $493,809 $13.08 09 Sep 2024 Direct
UroGen Pharma Ltd. Chief Financial Officer Restricted Stock Units 5,000 09 Sep 2024 Direct

Insider Reports Filed by Dong Kim

Symbol Company Period Transactions Value $ Form Type Role Filing Time
THAR Tharimmune, Inc. 27 Mar 2025 0 $0 3 CFO 27 Mar 2025, 19:00
URGN UroGen Pharma Ltd. 09 Sep 2024 2 $0 4 Chief Financial Officer 12 Sep 2024, 13:50
URGN UroGen Pharma Ltd. 31 Jan 2024 1 $0 4/A Chief Financial Officer 12 Feb 2024, 17:47
URGN UroGen Pharma Ltd. 31 Jan 2024 3 $0 4 Chief Financial Officer 02 Feb 2024, 19:05
URGN UroGen Pharma Ltd. 07 Sep 2023 1 $0 4 Chief Financial Officer 08 Sep 2023, 16:41
URGN UroGen Pharma Ltd. 31 Jan 2023 2 $0 4 Chief Financial Officer 02 Feb 2023, 12:05
URGN UroGen Pharma Ltd. 25 Mar 2022 1 $0 4/A Chief Financial Officer 12 Feb 2024, 17:43
URGN UroGen Pharma Ltd. 25 Mar 2022 1 $0 4 Chief Financial Officer 29 Mar 2022, 19:14
URGN UroGen Pharma Ltd. 25 Mar 2022 0 $0 3 Chief Financial Officer 29 Mar 2022, 19:11